HOME › DRUGS › HUMAN HETEROLOGOUS LIVER CELLS
ACTIVE SUBSTANCE / INN

HUMAN HETEROLOGOUS LIVER CELLS

Brand name(s): Heparesc
EMA LISTED
REFUSED
Urea Cycle Disorders, Inborn
ACTIVE SUBSTANCE
Human Heterologous Liver Cells
REGULATORS
EMA
SPONSORS / MAH
Cytonet GmbH KG
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
HeparescCytonet GmbH KGRefusedUrea Cycle Disorders, Inborn

FULL INTELLIGENCE ON HUMAN HETEROLOGOUS LIVER CELLS

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →